Numbers needed to treat to benefit (nntb) and to harm (nnth) for COVID-19 medicines

被引：0
|
作者：
Penedones, Ana [1 ]
Mendes, Diogo [2 ]
Alves, Carlos [1 ]
Marques, Francisco Batel [2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] Univ Coimbra, Fac Pharm, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
709
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [21] The 'number needed to treat' metric: a further marker of the impact of COVID-19 on malignant melanomas
    Granahan, Aoife
    Sazali, Hafsah
    Tummon, Olga
    Costigan, Orla
    Fleming, Louise
    Moriarty, Blaithin
    Lally, Aoife
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (07) : 1377 - 1379
  • [22] Rivaroxaban: An Evaluation of its Cardiovascular Benefit–Risk Profile Across Indications Based on Numbers Needed to Treat or Harm, and on Clinically Meaningful Endpoint Comparisons
    Ageno W.
    Drugs in R&D, 2015, 15 (4) : 295 - 306
  • [23] COVID-19: First Do No Harm
    Waterer, Grant W.
    Rello, Jordi
    Wunderink, Richard G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (11) : 1324 - 1325
  • [24] Molecular Mechanisms of the Medicines for COVID-19
    Komiyama, Makoto
    BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 2022, 95 (09) : 1308 - 1317
  • [25] Covid-19 and EMA Authorized Medicines
    Tesseromatis, C.
    Tounta, D.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S57 - S57
  • [26] Quantitative Benefit-Risk Assessment of Rosiglitazone: Number Needed to Treat, Number Needed to Harm and Likelihood to be Helped or Harmed
    Mendes, D.
    Alves, C.
    Batel-Marques, F.
    DRUG SAFETY, 2014, 37 (10) : 859 - 859
  • [27] Benefit-Risk Assessment Using Number Needed to Treat and Number Needed to Harm for Time-to-Event Endpoints
    Ke, Chunlei
    Jiang, Qi
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2016, 8 (04): : 379 - 385
  • [28] Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well
    Sedova, Petra
    Brown, Robert D., Jr.
    Bryndziar, Tomas
    Jarkovsky, Jiri
    Tomek, Ales
    Sramek, Martin
    Skoda, Ondrej
    Sramkova, Tereza
    Littnerova, Simona
    Mikulik, Robert
    CEREBROVASCULAR DISEASES, 2022, 51 (01) : 52 - 59
  • [29] New COVID-19 vaccines needed
    不详
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2022, 100 (02) : 92 - 92
  • [30] An inquiry into COVID-19 is needed now
    Puntis, John W.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (04)
12345